SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?


To: charles meade who wrote (919)3/8/1999 9:57:00 PM
From: Amy Feller  Read Replies (2) | Respond to of 1754
 
Charles..

Many thanks! The report is everything I think we longs have been expecting.

Amy



To: charles meade who wrote (919)5/10/1999 9:19:00 PM
From: charles meade  Respond to of 1754
 
A little index fund buying and selling....

S&P makes changes to SmallCap, MidCap indices: VISX Inc. (VISX) will move from the SmallCap 600 to the MidCap 400 on May 17, replacing Agouron Pharmaceuticals Inc. (AGPH ). Agouron is being acquired by S&P 500 component Warner-Lambert Co. (WLA).

See

biz.yahoo.com